Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endpoints in rheumatoid arthritis

P Tugwell1, M Boers, P Baker

  • 1Department of Medicine, University of Ottawa, Canada.

The Journal of Rheumatology. Supplement
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction.

Communications medicine·2026
Same author

A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the 'Plants for Joints' randomized controlled trials.

Scandinavian journal of rheumatology·2025
Same author

Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR.

Scandinavian journal of rheumatology·2025
Same author

At the core of measurement - What do you want to measure? And how do you want to measure it? A COSMIN perspective.

Journal of clinical epidemiology·2025
Same author

Longitudinal Speech Outcome at 5 and 10 Years in UCLP: Influence of Speech Therapy and Secondary Velopharyngeal Surgery.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2024
Same author

Scandcleft randomized trials of primary surgery for unilateral cleft lip and palate: Speech proficiency at 10 years of age.

International journal of language & communication disorders·2022

A core set of 8 outcome measures for rheumatoid arthritis (RA) clinical trials was established. Further research is needed to validate these measures and explore additional outcomes like toxicity and cost.

Area of Science:

  • Rheumatology
  • Clinical Trials
  • Outcome Measurement

Background:

  • The Outcome Measures in Rheumatology Trials (OMERACT) conference has been pivotal in advancing clinical outcome measurement.
  • Standardized outcome measures are crucial for consistent and comparable rheumatoid arthritis (RA) clinical trial results.

Purpose of the Study:

  • To establish a preliminary core set of 8 essential endpoints for RA clinical trials of one year or longer.
  • To outline the need for further validation and refinement of these core measures and their aggregation into indices.

Main Methods:

  • Consensus was reached on a preliminary core set of 8 outcome measures through conference discussions and nominal group exercises.
  • A mandate was established for comprehensive testing of assessment techniques, determination of clinical importance, and validation of aggregated outcome indices.

Related Experiment Videos

Main Results:

  • A preliminary core set of 8 endpoints was agreed upon for RA trials: acute phase reactants, disability, pain, patient and physician global assessments, swollen and tender joint counts, and radiographic joint assessments.
  • The conference identified the need for systematic exploration of additional outcomes, including drug toxicity, costs, and mortality, for definitive intervention selection.

Conclusions:

  • The established core set provides a minimum standard for RA clinical trials.
  • Further research and validation are essential to refine outcome measures, ensure credibility, and inform clinical decision-making, considering broader aspects beyond core endpoints.